نتائج البحث

1

Production of cellulase by Novosphingobium sp. Cm1 and its potential application in lignocellulosic waste hydrolysis

المؤلفون: Hari P. Dekaboruah, Kongkana Goswami, Ratul Saikia

المصدر: Preparative Biochemistry & Biotechnology. 52:724-735

مصطلحات موضوعية: biology, Chemistry, General Medicine, Cellulase, Pulp and paper industry, biology.organism_classification, Biochemistry, Enzyme assay, Carboxymethyl cellulose, Congo red, chemistry.chemical_compound, Hydrolysis, biology.protein, medicine, Yeast extract, Cellulose, Bacteria, Biotechnology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7b139ccdea34424a5360b95179bf491aTest
https://doi.org/10.1080/10826068.2021.1989698Test

2

Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial

المؤلفون: Frederick Lansigan, Jeff P. Sharman, Patrick M Travis, Ian W. Flinn, Michael S. Weiss, Kathryn S. Kolibaba, Jason C. Chandler, Stephen J. Schuster, Hari P. Miskin, Suman Kambhampati, Nilanjan Ghosh, Danielle M. Brander, Scott D. Lunin, John M. Burke, Mikhail Shtivelband, Anthony R. Mato, Alexander Zweibach, Peter Sportelli, Marshall T. Schreeder

المصدر: The Lancet Haematology. 8:e254-e266

مصطلحات موضوعية: Male, medicine.medical_specialty, Population, Administration, Oral, Neutropenia, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Agammaglobulinaemia Tyrosine Kinase, medicine, Clinical endpoint, Humans, Progression-free survival, Israel, Adverse effect, education, Protein Kinase Inhibitors, Aged, education.field_of_study, business.industry, Adenine, Antibodies, Monoclonal, Hematology, Middle Aged, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Progression-Free Survival, United States, Clinical trial, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Ibrutinib, Administration, Intravenous, Female, Safety, business, Febrile neutropenia, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc1704debdbf4edf7ce0038f0c02e284Test
https://doi.org/10.1016/s2352-3026Test(20)30433-6

3

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells

المؤلفون: Eva Sahakian, Dave Maryanski, Andrii Monastyrskyi, Kamira Maharaj, Karen L. Burger, Hari P. Miskin, Kun Jiang, Derek R. Duckett, John L. Cleveland, William R. Roush, Wael Gamal, Melanie Mediavilla-Varela, Renee Fonseca, Alex Achille, Javier Pinilla-Ibarz, John Powers

المصدر: Blood Adv

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ffc5f958a1d29f55efb4ce6f93d8aedTest
https://doi.org/10.1182/bloodadvances.2020001800Test

4

Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study

المصدر: Blood. 136:37-39

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chlorambucil, business.industry, Chronic lymphocytic leukemia, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Therapy naive, chemistry.chemical_compound, chemistry, Obinutuzumab, Internal medicine, Relapsed refractory, medicine, In patient, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3b709026b6839fc03b0b3e79475cb12bTest
https://doi.org/10.1182/blood-2020-134783Test

5

Multicenter Evaluation of Ceftazidime-Avibactam Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa on the Vitek 2 System

المؤلفون: Hari P. Dwivedi, Lisa Heimbach, Simone Franklin, Shelley Campeau, Romney Humphries, Kristin Nagaro, Vincent LaBombardi, Thomas E. Davis

المصدر: Journal of Clinical Microbiology. 59

مصطلحات موضوعية: Microbiology (medical), medicine.medical_specialty, Susceptibility testing, business.industry, Pseudomonas aeruginosa, Avibactam, Broth microdilution, Ceftazidime, Ceftazidime/avibactam, medicine.disease_cause, chemistry.chemical_compound, chemistry, Internal medicine, Enterobacterales, medicine, Overall performance, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e529f91ec4ab3a9db9c5d1b9b4833ac2Test
https://doi.org/10.1128/jcm.01870-20Test

6

Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial

المؤلفون: Marshall T. Schreeder, Julie M. Vose, Matthew A. Lunning, Susan O'Brien, Hari P. Miskin, Loretta J. Nastoupil, Michael S. Weiss, Christopher R. Flowers, William G. Wierda, Jan A. Burger, Jonathon B. Cohen, M. Purdom, Nathan Fowler, Tanya Siddiqi, Peter Sportelli

المصدر: The Lancet Haematology. 6:e100-e109

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5f02e8be3a1a57458e5d8a31ddcc978Test
https://doi.org/10.1016/s2352-3026Test(18)30216-3

7

Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study

المؤلفون: Laura Stampleman, Eric D. Jacobsen, Rodrigo O. Maegawa, Matthew S. Davids, Adam M. Boruchov, Hari P. Miskin, Caron A. Jacobson, Jennifer R. Brown, Karen Francoeur, David C. Fisher, Peter Sportelli, Alyssa Nicotra, Alexandra Savell, Jon E. Arnason, Josie Bazemore, Haesook T. Kim, Jens Rueter, Jeffrey M Hellman

المصدر: The Lancet Haematology. 6:e38-e47

مصطلحات موضوعية: Male, medicine.medical_specialty, Receptors, Antigen, B-Cell, Lymphoma, Mantle-Cell, Heterocyclic Compounds, 4 or More Rings, Gastroenterology, Article, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, Refractory, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Adverse effect, neoplasms, Protein Kinase Inhibitors, Aged, Aged, 80 and over, business.industry, Adenine, Hematology, Middle Aged, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Clinical trial, Leukemia, Pyrimidines, chemistry, 030220 oncology & carcinogenesis, Ibrutinib, Transaminitis, Pyrazoles, Female, Mantle cell lymphoma, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce19e798ec50af9506297a2cef019b1Test
https://doi.org/10.1016/s2352-3026Test(18)30196-0

8

Use of DNA aptamer for sandwich type detection of Listeria monocytogenes

المؤلفون: Blanca I. Escudero-Abarca, Soo Jung Choi, Lee-Ann Jaykus, Soo Hwan Suh, Hari P. Dwivedi, Matthew D. Moore

المصدر: Analytical Biochemistry. 557:27-33

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998759115b37bb248e2ca9ab47d023e7Test
https://doi.org/10.1016/j.ab.2018.04.009Test

9

Rate coefficients of hydroxyl radical reaction with dimethyl ether over a temperature range of 257–333 K

المؤلفون: Monali Kawade, D. Srinivas, Hari P. Upadhyaya, Awadhesh Kumar, Ankur Saha, Prakash D. Naik, Asmita Sharma

المصدر: Chemical Physics Letters. 706:558-563

مصطلحات موضوعية: Reaction mechanism, 010504 meteorology & atmospheric sciences, Chemistry, General Physics and Astronomy, Radiative forcing, Atmospheric temperature range, 010402 general chemistry, 01 natural sciences, Fluorescence, Transition state, 0104 chemical sciences, chemistry.chemical_compound, Physical chemistry, Hydroxyl radical, Dimethyl ether, Experimental work, Physical and Theoretical Chemistry, 0105 earth and related environmental sciences

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cdc77b6baf9248a5586fab1a12b9c41cTest
https://doi.org/10.1016/j.cplett.2018.06.065Test

10

A Phase 2 Study Evaluating the Addition of Ublituximab and Umbralisib (U2) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): A Minimal Residual Disease (MRD)-Driven, Time-Limited Approach

المصدر: Blood. 138:395-395

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Chronic lymphocytic leukemia, Immunology, Phases of clinical research, Cell Biology, Hematology, medicine.disease, Biochemistry, Minimal residual disease, chemistry.chemical_compound, chemistry, Internal medicine, Ibrutinib, medicine, In patient, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cfdbc6ce69bcf6964d1d31afce0cb006Test
https://doi.org/10.1182/blood-2021-146999Test

تنقيح النتائج